ALEC vs BIO · rev $4.4M vs rev $651.0M
Alector Inc (ALEC) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Alector Inc (ALEC) is a biotechnology company listed on US.
BIO (BIO) common stock.
Latest reported ALEC revenue for 2026-06-30 was $4.4M. Net income was -$45.9M. ALEC currently screens at market cap $216.5M.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
ALEC currently screens at market cap $216.5M. BIO currently screens at market cap $0.
Not investment advice. Open the ALEC and BIO stock pages for the full models.
Not investment advice.